Peptidyl cyclopropenones: reversible inhibitors, irreversible inhibitors, or substrates of cysteine proteases?

Protein Sci. 2013 Jun;22(6):788-99. doi: 10.1002/pro.2260. Epub 2013 Apr 29.

Abstract

Peptidyl cyclopropenones were previously introduced as selective cysteine protease reversible inhibitors. In the present study we synthesized one such peptidyl cyclopropenone and investigated its interaction with papain, a prototype cysteine protease. A set of kinetics, biochemical, HPLC, MS, and (13)C-NMR experiments revealed that the peptidyl cyclopropenone was an irreversible inhibitor of the enzyme, alkylating the catalytic cysteine. In parallel, this cyclopropenone also behaved as an alternative substrate of the enzyme, providing a product that was tentatively suggested to be either a spiroepoxy cyclopropanone or a gamma-lactone. Thus, a single family of compounds exhibits an unusual variety of activities, being reversible inhibitors, irreversible inhibitors and alternative substrates towards enzymes of the same family.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkylation / drug effects
  • Catalytic Domain / drug effects
  • Cyclopropanes / chemistry*
  • Cyclopropanes / pharmacology*
  • Cysteine Proteinase Inhibitors / chemistry*
  • Cysteine Proteinase Inhibitors / pharmacology*
  • Papain / antagonists & inhibitors*
  • Papain / chemistry
  • Papain / metabolism

Substances

  • Cyclopropanes
  • Cysteine Proteinase Inhibitors
  • cyclopropenone
  • Papain